Tag: Anti-Kickback Statute

PHARMACEUTICAL WHISTLEBLOWER BLOG: Pharmaceutical Company Daiichi to Pay $39 Million to Settle Fraud Allegations Involving Improper Kickbacks

On January 9, 2015, the Department of Justice announced that Daiichi Sankyo Inc., a global pharmaceutical company with its U.S. headquarters in New Jersey, agreed to pay the federal government and state Medicaid programs $39 million to ...

Continue reading

ANTI-KICKBACK STATUTE WHISTLEBLOWER BLOG: DaVita To Pay $350 Million to Resolve Whistleblower Lawsuit Alleging Illegal Kickback Arrangements With Referring Physicians

DaVita Healthcare Partners, Inc., recently agree to pay $350 million to the federal government to settle a whistleblower lawsuit alleging that it violated the civil False Claims Act. The settlement resolves allegations originally ...

Continue reading

HOME HEALTH WHISTLEBLOWER BLOG: Florida HHA to Pay $1.65 Million to Settle FCA Whistleblower Lawsuit Alleging Home Health Fraud

The Department of Justice recently announced that A Plus Home Health Care, Inc., and its owners, have agreed to pay $1.65 million to the federal government to settle allegations of Home Health Fraud set forth in a whistleblower lawsuit ...

Continue reading

PHARMACEUTICAL WHISTLEBLOWER BLOG: Whistleblower Lawsuit Against Novartis Survives Motion to Dismiss

Recently, a federal district judge in the Southern District of New York denied, in part, Novartis’ motion to dismiss a whistleblower lawsuit filed under the civil False Claims Act. The pharmaceutical whistleblower alleged that Novartis ...

Continue reading

HOME HEALTH WHISTLEBLOWER BLOG: Amedisys to Pay $150 Million to Settle Whistleblower Lawsuit

A whistleblower lawsuit brought under the federal False Claims Act has resulted in a government recovery from one of the largest home health agencies. In April 2014, the Department of Justice announced that the home health agency ...

Continue reading

Menu Title